polidocanol · Boston Scitfc · NDA 205098
Varithena
Earliest generic entry, as listed
12 May 2032
Blocked by patent: US 9480652.
Listed patents · 2 unexpired
| Patent | Claims | Expires |
|---|---|---|
| US 9480652 | product | 12 May 2032 |
| US 7814943 | product, use U-1461 | 19 Nov 2027 |
Exclusivities · 0 unexpired
No unexpired exclusivities listed.
Paragraph IV certifications · 0
No Paragraph IV certification listed by FDA for this drug.
The list shows that a generic applicant certified to FDA that a listed patent is invalid or not infringed. It does not show litigation, settlements or launch timing.
Event history
No events yet. The first ingestion only records products entering their 12-month window; changes appear from the next Orange Book update.
Products covered · 2
| NDA · product | Form | Strength | Listed expiry |
|---|---|---|---|
| 205098 · 001 · RLD | solution, intravenous | 180MG/18ML (10MG/ML) | 12 May 2032 |
| 205098 · 002 · RLD · discontinued | solution, intravenous | 77.5MG/7.75ML (10MG/ML) | open |